Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
54.43
+0.11 (0.20%)
At close: Sep 14, 2026, 4:00 PM EDT
54.00
-0.43 (-0.79%)
Pre-market: Sep 15, 2026, 6:34 AM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $3.99 billion as of September 14, 2026. Its market cap has increased by 237.31% in one year.
Market Cap
3.99B
Enterprise Value
3.09B
1-Year Change
237.31%
Ranking
Category
Stock Price
$54.43
ChartMarket Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $3.99B, an increase of 309.45%. That is a compound annual growth rate of 48.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 3.99B | 336.36% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 4.14B |
| Veradermics | 4.13B |
| Celcuity | 4.08B |
| Tango Therapeutics | 4.01B |
| Telix Pharmaceuticals | 3.98B |
| Iovance Biotherapeutics | 3.90B |
| Viking Therapeutics | 3.73B |
| IDEAYA Biosciences | 3.63B |